Litcius/Paper detail

<i>Lactobacillus rhamnosus</i> Sepsis Associated with Probiotic Therapy in a Term Infant with Congenital Heart Disease

Seda Aydoğan, Dílek Díllí, Ahmet Özyazıcı, Nesibe Nur Aydın, Hüsniye Şimşek, Utku Arman Örün, Ömer Nuri Aksoy

2021Fetal and Pediatric Pathology15 citationsDOI

Abstract

BACKGROUND: Congenital heart diseases (CHD) are the most common birth defects. Necrotizing enterocolitis (NEC) is an important cause of morbidity and mortality in premature infants, and probiotics can be used to protect NEC. CASE REPORT: GG after probiotic use, successfully treated with ampicillin. The baby unfortunately died of acute cardiac arrest on the 90th day of life. CONCLUSION: Probiotic-associated sepsis may develop in infants with various risk factors such as central catheterization, long-term mechanical ventilation and in those at risk for NEC.

Topics & Concepts

MedicineLactobacillus rhamnosusNecrotizing enterocolitisProbioticSepsisHeart diseasePediatricsDiseaseEnterocolitisIntensive care medicineInternal medicineGeneticsBacteriaBiologyInfant Nutrition and HealthInfant Health and DevelopmentProbiotics and Fermented Foods
<i>Lactobacillus rhamnosus</i> Sepsis Associated with Probiotic Therapy in a Term Infant with Congenital Heart Disease | Litcius